Aaron McCullough

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
4030 Background: Dual inhibition of the EGFR pathway using erlotinib and panitumumab results in greater antitumor activity in preclinical pancreatic cancer models. A trial to evaluate this approach(More)